About this trial
Chronic refractory plantar fasciopathy is a common musculoskeletal condition that can cause persistent heel pain and functional limitations despite conservative treatment. When symptoms do not improve, patients often face the decision between continuing non-surgical management or undergoing surgery. However, direct comparative evidence between these treatment strategies is limited.
This multicenter controlled trial aims to compare the effectiveness of a multimodal conservative intervention consisting of manual therapy and ultrasound-guided percutaneous neuromodulation with endoscopic plantar fascial release followed by standard postoperative rehabilitation in adults with chronic refractory plantar fasciopathy.
A total of 120 participants will be allocated to treatment groups according to their informed treatment preference within a shared decision-making process. The primary outcome will be the change in the Foot Function Index (FFI) after 6 weeks. Secondary outcomes include pain intensity, health-related quality of life, treatment adherence, adverse events, and exploratory neurophysiological measures. The results are expected to provide evidence to support clinical decision-making and optimize the management of patients with chronic refractory plantar fasciopathy.
Eligibility criteria
Qualifiers
Adults aged 30 to 65 years.
Diagnosis of chronic refractory plantar fasciopathy with symptom duration greater than 6 months.
Failure of at least two previous conservative treatments, each lasting at least 12 weeks.
Foot Function Index (FFI) total score ≥45 points.
Disqualifiers
Previous foot surgery on the affected side.
Calcaneal stress fracture.
Glycated hemoglobin (HbA1c) >7.5%.
Inability or unwillingness to comply with study procedures or follow-up assessments.
Trial design
Treatments tested in this trial
- Multimodal Conservative Intervention
- Endoscopic Plantar Fascial Release